bretylium tosylate has been researched along with quinidine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (80.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Binnion, PF; Das Gupta, R | 1 |
| Lucchesi, BR | 1 |
| Bigger, JT; Heissenbuttel, RH | 1 |
| Au, T; Garnett, ME; Godin, DV | 1 |
| Fiehring, H; Steffen, V | 1 |
| Kahn, DR; Reynolds, EW; Tullett, G; VanderArk, CR | 1 |
| Inoue, H; Sugimoto, T | 1 |
| Somberg, J | 1 |
| Huang, SK; Marcus, FI | 1 |
| Balazs, T; Ehrreich, SJ; el-Hage, AN; Johnson, GL | 1 |
| Davy, JM; Dorian, P; Fain, ES; Winkle, RA | 1 |
| Inoue, H; Matsuo, H; Nozaki, A; Sugimoto, T; Toda, I | 1 |
| DiBianco, R; Fletcher, RD; Gottdiener, JS | 1 |
| Somberg, JC | 1 |
| DePace, NL; Morganroth, J; Nestico, PF | 1 |
| Moses, HW; Yu, PN | 1 |
8 review(s) available for bretylium tosylate and quinidine
| Article | Year |
|---|---|
Prophylactic antiarrhythmic drug therapy in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bretylium Tosylate; Humans; Lidocaine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine | 1975 |
Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
Topics: Action Potentials; Adrenergic Fibers; Animals; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Drug Evaluation; Drug Interactions; Drug Resistance; Heart Conduction System; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Myocardial Contraction; Myocardial Infarction; Pharmaceutical Vehicles; Purkinje Fibers; Quinidine; Sympathetic Nervous System; Tachycardia; Ventricular Fibrillation | 1979 |
[Bretylium tosylate as an anti-arrhythmic drug].
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Bretylium Compounds; Bretylium Tosylate; Digitalis Glycosides; Dose-Response Relationship, Drug; Drug Incompatibility; Heart Rate; Humans; Hypotension; Quinidine; Stimulation, Chemical; Vascular Resistance | 1976 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Effects of antiarrhythmic agents on cardiac function.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Dogs; Encainide; Hemodynamics; Humans; Myocardial Contraction; Quinidine; Verapamil | 1982 |
Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Heart Ventricles; Humans; Lidocaine; Procainamide; Propranolol; Quinidine; Tocainide | 1984 |
Antiarrhythmic drugs.
Topics: Anti-Arrhythmia Agents; Bretylium Tosylate; Disopyramide; Humans; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1980 |
12 other study(ies) available for bretylium tosylate and quinidine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Drugs used in the care of the cardiac patient.
Topics: Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Atropine; Bretylium Tosylate; Cardiac Glycosides; Cardiovascular Diseases; Digitalis Glycosides; Disopyramide; Diuretics; Dose-Response Relationship, Drug; Humans; Isoproterenol; Lidocaine; Myocardial Contraction; Propranolol; Quinidine | 1978 |
Antiarrhythmic drugs. Key references.
Topics: Anti-Arrhythmia Agents; Bibliographies as Topic; Bretylium Tosylate; Lidocaine; Procainamide; Propranolol; Quinidine | 1979 |
Membrane perturbational effects of antiarrhythmic drugs.
Topics: Anti-Arrhythmia Agents; Bretylium Tosylate; Dithionitrobenzoic Acid; Dose-Response Relationship, Drug; Erythrocyte Membrane; Erythrocytes; Hemolysis; Lidocaine; Membrane Lipids; Membrane Proteins; Phospholipids; Practolol; Propranolol; Quinidine; Trinitrobenzenesulfonic Acid | 1979 |
Quinidine syncope. A report of successful treatment with bretylium tosylate.
Topics: Adult; Atrial Fibrillation; Bretylium Compounds; Bretylium Tosylate; Electrocardiography; Female; Humans; Middle Aged; Quinidine; Syncope; Tachycardia | 1976 |
Torsades de pointes and ventricular fibrillation in a canine model of quinidine-induced QT prolongation.
Topics: Animals; Bretylium Tosylate; Cardiac Pacing, Artificial; Dogs; Female; Heart Conduction System; Isoproterenol; Lidocaine; Long QT Syndrome; Male; Models, Cardiovascular; Quinidine; Torsades de Pointes; Ventricular Fibrillation | 1992 |
Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
Topics: Animals; Anti-Arrhythmia Agents; Body Weight; Bretylium Tosylate; Death, Sudden; Disease Models, Animal; Electrocardiography; Isoproterenol; Male; Niacin; Phenytoin; Procainamide; Propranolol; Quaternary Ammonium Compounds; Quinidine; Rats; Ventricular Fibrillation; Verapamil | 1986 |
Effect of quinidine and bretylium on defibrillation energy requirements.
Topics: Animals; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Dogs; Electric Countershock; Models, Biological; Quinidine; Ventricular Fibrillation | 1986 |
Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval.
Topics: Animals; Blood Pressure; Bretylium Compounds; Bretylium Tosylate; Disease Models, Animal; Dogs; Female; Heart; Male; Quinidine; Tachycardia; Ventricular Fibrillation | 1985 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |